2002
DOI: 10.1242/dev.129.4.1075
|View full text |Cite
|
Sign up to set email alerts
|

A mouse model of Alagille syndrome:Notch2as a genetic modifier ofJag1haploinsufficiency

Abstract: Alagille syndrome is a human autosomal dominant developmental disorder characterized by liver, heart, eye, skeletal, craniofacial and kidney abnormalities. Alagille syndrome is caused by mutations in the Jagged 1 (JAG1) gene, which encodes a ligand for Notch family receptors. The majority of JAG1 mutations seen in Alagille syndrome patients are null alleles, suggesting JAG1 haploinsufficiency as a primary cause of this disorder. Mice homozygous for a Jag1 null mutation die during embryogenesis and Jag1/+ heter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 426 publications
(22 citation statements)
references
References 51 publications
1
18
0
Order By: Relevance
“…Previous studies have shown that NOTCH1 plays a role in mediating lateral inhibition postnatally, and in preventing continued proliferation [ 72 , 73 ]. NOTCH2 is also a possible receptor given that it acts as the receptor for JAG1 in other systems that are affected in Alagille syndrome [ 74 ]. Thus, NOTCH1 and NOTCH2 are possible receptors based on established roles in the cochlea or other systems, but NOTCH1, NOTCH2, NOTCH3, or a combination of these receptors, could mediate the effects of JAG1 in the maturing cochlea.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that NOTCH1 plays a role in mediating lateral inhibition postnatally, and in preventing continued proliferation [ 72 , 73 ]. NOTCH2 is also a possible receptor given that it acts as the receptor for JAG1 in other systems that are affected in Alagille syndrome [ 74 ]. Thus, NOTCH1 and NOTCH2 are possible receptors based on established roles in the cochlea or other systems, but NOTCH1, NOTCH2, NOTCH3, or a combination of these receptors, could mediate the effects of JAG1 in the maturing cochlea.…”
Section: Discussionmentioning
confidence: 99%
“…AGS is a genetic disorder caused by mutations in JAG1 and NOTCH2, which are components of the NOTCH signaling pathway associated with the development of multiple organs, 18,19 including bile duct and cardiovascular system 20,21 Because the disease is most common in childhood and highly variable across patients, 22 AGS is underdiagnosed in adults, especially those without a family history. The patients in this study were from 16 to 56 years of age.…”
Section: Discussionmentioning
confidence: 99%
“…If the first-degree relatives of the patient had been diagnosed with ALGS, then this is considered sufficient for the patient to be diagnosed with ALGS as long as the patient met the two classic criteria ( 8 , 9 ). NOTCH 2 gene mutation was identified as a pathogenic gene in the JAG1/NOTCH2 double heterozygous mouse model in 2002 ( 10 ). In 2006, McDaniell et al found that 5 out of 11 ALGS probands who were JAG 1 mutation-negative possessed a NOTCH 2 mutation and showed renal involvement, including small kidneys with cysts bilaterally and dysplastic kidneys ( 11 ).…”
Section: Discussionmentioning
confidence: 99%